Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar-Apr;9(2):90-95.
doi: 10.4103/idoj.IDOJ_137_17.

Is Antifungal Resistance a Cause for Treatment Failure in Dermatophytosis: A Study Focused on Tinea Corporis and Cruris from a Tertiary Centre?

Kabir Sardana  1 , Ravinder Kaur  2 , Pooja Arora  1 , Ritu Goyal  3 , Sneha Ghunawat  4
Affiliations

Is Antifungal Resistance a Cause for Treatment Failure in Dermatophytosis: A Study Focused on Tinea Corporis and Cruris from a Tertiary Centre?

Kabir Sardana et al. Indian Dermatol Online J. 2018 Mar-Apr.

Abstract

Background: Dermatophytoses are one of the most common skin diseases that have been largely simple to treat. However, in recent years, these infections have become recalcitrant to treatment which can possibly be due to antifungal resistance.

Aim: To analyze the resistance pattern of patients with recalcitrant dermatophytoses.

Materials and methods: A cross-sectional evaluation was undertaken of 40 consecutive patients with recalcitrant tinea corporis/cruris/both who had taken systemic antifungal treatment and did not respond completely to therapy or had recurrent lesion within 1 month of stopping the therapy. Terbinafine, fluconazole, itraconazole, ketoconazole, amphotericin B, and voriconazole were the antifungals tested using broth microdilution assay for antifungal susceptibility testing of dermatophytes, and MIC50, 90 values were recorded.

Results: KOH mount was positive in 18 (45%) patients, culture was positive in 28 (70%) patients. Trichophyton mentagrophytes (35%) and T. rubrum (27.5%) were the predominant isolates. Overall, activity of terbinafine and itraconazole were significantly higher than the other drugs tested. For terbinafine, both T. mentagrophytes and T. rubrum were inhibited at MIC90 of 0.125 μg/ml. Itraconazole-inhibited T. mentagrophytes and T. rubrum at MIC90 of 0.0625 and 0.25 μg/ml, respectively. All isolates had reduced susceptibility to fluconazole.

Conclusion: While MIC seen were higher than western data, in-vitro resistance (>1 μg/ml) to antifungals was not seen and probably may not be a cause of treatment failure. Possibly, treatment failure lies in the intricate host fungal interaction and virulence of species which help it to evade host immune response.

Keywords: Antifungals; MIC; dermatophytosis; itraconazole; resistance; terbinafine; tinea.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

References

    1. Lever LR, Dykes PJ, Thomas R, Finlay A. How orally administered terbinafine reaches the stratum corneum. J Dermatol Treat. 1990;1:23–5.
    1. Piérard G, Arrese J, De Doncker P. Antifungal activity of itraconazole and terbinafine in human stratum corneum: A comparative study. J Am Acad Dermatol. 1995;32:429–35. - PubMed
    1. Kaur R, Panda PS, Sardana K, Khan S. Mycological Pattern of Dermatomycoses in a Tertiary Care Hospital. J Trop Med 2015. 2015:157828. - PMC - PubMed
    1. Reference method for Broth Dilution Antifungal Susceptibility Testing of filamentous fungi; Approved Standard, 2nd edn. CLSI Document m38-A2. Wayne, PA: Clinical and Laboratory Standard Institute; 2008. CLSI.
    1. Ghannoum MA, Chaturvedi V, Espinel-Ingroff A, Pfaller MA, Rinaldi MG, Lee-Yang W, et al. Intra- and interlaboratory study of a method for testing the antifungal susceptibilities of dermatophytes. J Clin Microbiol. 2004;42:2977–9. - PMC - PubMed